Characterization of methionine dependence in melanoma cells
Molecular Omics · 2023
DOI: 10.1039/d3mo00087g ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Omics, 2023. Verfasst von Sarita Garg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. iracinemiousse@uams.edu. Hauptthemen laut MEDLINE: Methionine, Melanoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIGMS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Dietary methionine restriction is associated with a reduction in tumor growth in preclinical studies and an increase in lifespan in animal models. The mechanism by which methionine restriction inhibits tumor growth while sparing normal cells is incompletely understood. We do know that normal cells can utilize methionine or homocysteine interchangeably (methionine independence) while most cancer cells are strictly dependent on methionine availability. Here, we compared a typical methionine dependent and a rare methionine independent melanoma cell line. We show that replacing methionine, a methyl donor, with its precursor homocysteine generally induced hypomethylation in gene promoters. This decrease was similar in methionine dependent and methionine independent cells. There was only a low level of pathway enrichment, suggesting that the hypomethylation is generalized rather than gene specific. Whole proteome and transcriptome were also analyzed. This analysis revealed that contrarily to the effect on methylation, the replacement of methionine with homocysteine had a much greater effect on the transcriptome and proteome of methionine dependent cells than methionine independent cells. Interestingly, methionine adenosyltransferase 2A (MAT2A), responsible for the synthesis of S-adenosylmethionine from methionine, was equally strongly upregulated in both cell lines. This suggests that the absence of methionine is equally detected but triggers different outcomes in methionine dependent versus independent cells. Our analysis reveals the importance of cell cycle control, DNA damage repair, translation, nutrient sensing, oxidative stress and immune functions in the cellular response to methionine stress in melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. iracinemiousse@uams.edu.
Förderung
- NCATS NIH HHS
- NIGMS NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of General Medical Sciences
Zitieren
APA
Garg, S., Morehead, L. C., Bird, J. T., Graw, S., Gies, A., Storey, A. J., Tackett, A. J., Edmondson, R. D., Mackintosh, S. G., Byrum, S. D., & Miousse, I. R. (2023). Characterization of methionine dependence in melanoma cells. Molecular Omics. https://doi.org/10.1039/d3mo00087g
Vancouver
Garg S, Morehead LC, Bird JT, Graw S, Gies A, Storey AJ, et al. Characterization of methionine dependence in melanoma cells. Molecular Omics. 2023. doi:10.1039/d3mo00087g
BibTeX
@article{Garg2023,
author = {Garg, Sarita and Morehead, Lauren C and Bird, Jordan T and Graw, Stefan and Gies, Allen and Storey, Aaron J and Tackett, Alan J and Edmondson, Rick D and Mackintosh, Samuel G and Byrum, Stephanie D and Miousse, Isabelle R},
title = {Characterization of methionine dependence in melanoma cells},
journal = {Molecular Omics},
year = {2023},
doi = {10.1039/d3mo00087g}
}
EUVIMED